BioGPS
  • Home
  • Help
  • Plugins
  • Datasets
  • Sign Up
  • Login
Examples: Gene Symbol(s), Gene Ontology, Splicing plugins, Melanoma datasets
advanced
Home › Dataset Library › Transcription profiling by array of skeletal muscle in TypeII diabetes patients

Dataset: Transcription profiling by array of skeletal muscle in TypeII diabetes patients

Skeletal muscle mitochondrial dysfunction is secondary to T2DM and can be improved by long-term regular exercise training Mitochondrial...

Registered by ArrayExpress Uploader
View Dataset

Skeletal muscle mitochondrial dysfunction is secondary to T2DM and can be improved by long-term regular exercise training Mitochondrial dysfunction has long been implicated to play a causative role in development of type 2 diabetes (T2DM). However, a growing number of recent studies provide data that mitochondrial dysfunction is a consequence of T2DM development. The aim of our study is to clarify in further detail the causal role of mitochondrial dysfunction in T2DM by a comprehensive ex vivo analysis of mitochondrial function combined with global gene expression analysis in muscle of pre-diabetic newly diagnosed untreated T2DM subjects and long-standing insulin treated T2DM subjects compared with age- and BMI-matched controls. In addition, we assessed the impact of long-term interval exercise training on physical activity performance, mitochondrial function and glycemic control in long-standing insulin-treated T2DM subjects. Ex vivo mitochondrial density, quality and functioning was comparable between pre-diabetic subjects and matched controls, however, gene expression analysis showed a switch from carbohydrate toward lipids as energy source in pre-diabetes subjects. In contrast, long-term insulin treated T2DM subjects had slightly decreased mitochondrial density and ex vivo function. Expression of Krebs cycle and OXPHOS related genes were decreased, indicating a decreased capacity to use lipids as an energy source. The insulin-treated T2DM subjects had a lower physical activity level than pre-diabetic and normoglycemic subjects. A 52 weeks exercise training of these subjects increased submaximal oxidative efficiency, increased in vivo PCr recovery rate, as well as mildly increased in vitro mitochondrial function. Gene expression of β-oxidation, Krebs cycle and OXPHOS-related genes was increased. Our data demonstrate that mitochondrial dysfunction is rather a consequence than a causative factor in T2DM development as it was only detected in overt diabetes and not in early diabetes. Regular exercise training stabilized exogenous insulin requirement and improved mitochondrial functioning, fatty acid oxidation and general physical work load capacity in long-standing insulin-treated T2DM subjects. As such, the present study shows for the first time that long-term exercise interventions are beneficial in this group of complex diabetes patient and may prevent further metabolic deterioration. Insulin-treated T2DM subjects before and after 52 weeks of exercise training (T2DM_0 and T2DM_52), normoglycemic controls (NGT) and pre-diabetes subjects (IGT) and were selected. RNA was extracted from skeletal muscle biopsies and hybridized on Affymetrix microarrays.

Species:
human

Samples:
42

Source:
E-GEOD-19420

Updated:
Dec.12, 2014

Registered:
Sep.15, 2014


Factors: (via ArrayExpress)
Sample DISEASE STATE AGE TREATMENT BODY MASS INDEX
GSM482933 pre-diabetes control 67 not applicable 33.44
GSM482934 normoglycemic control 59 not applicable 37.22
GSM482935 pre-diabetes control 48 not applicable 36.3
GSM482936 type 2 diabetes mellitus 64 control 29.03
GSM482937 type 2 diabetes mellitus 64 exercise training 29.03
GSM482938 normoglycemic control 57 not applicable 39.71
GSM482939 pre-diabetes control 58 not applicable 30.16
GSM482940 type 2 diabetes mellitus 67 control 31.23
GSM48294 type 2 diabetes mellitus 67 exercise training 31.23
GSM482942 type 2 diabetes mellitus 56 control 31.9
GSM482943 type 2 diabetes mellitus 56 exercise training 31.9
GSM482944 pre-diabetes control 57 not applicable 37.24
GSM482945 normoglycemic control 59 not applicable 31.89
GSM482946 type 2 diabetes mellitus 54 control 35.15
GSM482947 normoglycemic control 56 not applicable 27.17
GSM482948 normoglycemic control 49 not applicable 33.59
GSM482949 type 2 diabetes mellitus 66 control 34.11
GSM482950 type 2 diabetes mellitus 66 exercise training 34.11
GSM48295 type 2 diabetes mellitus 51 control 32.65
GSM482952 type 2 diabetes mellitus 51 exercise training 32.65
GSM482953 pre-diabetes control 61 not applicable 32.01
GSM482954 type 2 diabetes mellitus 68 control 38.72
GSM482955 type 2 diabetes mellitus 49 control 25.47
GSM482956 type 2 diabetes mellitus 49 exercise training 25.47
GSM482957 normoglycemic control 64 not applicable 32.98
GSM482958 normoglycemic control 61 not applicable 29.24
GSM482959 pre-diabetes control 60 not applicable 35.58
GSM482960 normoglycemic control 62 not applicable 36.24
GSM48296 normoglycemic control 49 not applicable 27.62
GSM482962 pre-diabetes control 57 not applicable 27.47
GSM482963 pre-diabetes control 54 not applicable 28.73
GSM482964 type 2 diabetes mellitus 60 control 32.79
GSM482965 type 2 diabetes mellitus 60 exercise training 32.79
GSM482966 pre-diabetes control 54 not applicable 41.21
GSM482967 pre-diabetes control 62 not applicable 29.71
GSM482968 normoglycemic control 48 not applicable 31.5
GSM482969 pre-diabetes control 58 not applicable 32.74
GSM482970 normoglycemic control 61 not applicable 27.86
GSM48297 pre-diabetes control 56 not applicable 30.09
GSM482972 type 2 diabetes mellitus 66 control 36.33
GSM482973 type 2 diabetes mellitus 66 exercise training 36.33
GSM482974 normoglycemic control 48 not applicable 40.29

Tags

  • carbohydrate
  • fatty acid
  • insulin
  • muscle

Other Formats

JSON    XML
  • About
  • Blog
  • Help
  • FAQ
  • Downloads
  • API
  • iPhone App
  • Email updates
© 2025 The Scripps Research Institute. All rights reserved. (ver 94eefe6 )
  • Terms of Use